MATRIX CAPITAL MANAGEMENT COMPANY, LP – Adaptimmune Therapeutics plc Transaction History
MATRIX CAPITAL MANAGEMENT COMPANY, LP portfolio value:
$41.89M
portfolio value
MATRIX CAPITAL MANAGEMENT COMPANY, LP quarter portfolio value change:
-36.76%
quarter
Adaptimmune Therapeutics plc 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | 0.00% | 0 shares | -24.35M | $1.08 | 38.97M | |
Q2 2022 | share | 0.00% | 0 shares | -14.03M | $1.7 | 38.97M | |
Q1 2022 | share | 0.00% | 0 shares | -65.86M | $2.06 | 38.97M | |
Q4 2021 | share | 0.00% | 0 shares | -55.34M | $3.87 | 38.97M | |
Q3 2021 | share | 0.00% | 0 shares | 35.46M | $5.17 | 38.97M | |
Q2 2021 | share | 0.00% | 0 shares | -40.92M | $4.26 | 38.97M | |
Q1 2021 | share | 0.00% | 0 shares | -3.11M | $5.31 | 38.97M | |
Q4 2020 | share | 0.00% | 0 shares | -100.94M | $5.39 | 38.97M | |
Q3 2020 | share | 0.00% | 0 shares | -79.11M | $7.98 | 38.97M | |
Q2 2020 | share | Increase | +13.20% | 4.54M shares | 296.48M | $10.01 | 38.97M |
Q1 2020 | share | Increase | +22.96% | 6.42M shares | 60.04M | $2.72 | 34.42M |
Q4 2019 | share | 0.00% | 0 shares | -8.68M | $1.2 | 28M | |
Q3 2019 | share | 0.00% | 0 shares | -70.28M | $1.51 | 28M | |
Q2 2019 | share | 0.00% | 0 shares | -7.84M | $4.02 | 28M | |
Q1 2019 | share | Increase | +3.13% | 851K shares | -35.70M | $4.3 | 28M |
Q4 2018 | share | Increase | +33.33% | 6.78M shares | -120.00M | $5.75 | 27.14M |
Q3 2018 | share | Increase | +44.58% | 6.27M shares | 108.93M | $13.56 | 20.36M |
Q2 2018 | share | Increase | +1.45% | 201.5K shares | 11.27M | $11.87 | 14.08M |
Q1 2018 | share | Increase | +13.66% | 1.66M shares | 74.30M | $11.23 | 13.88M |
Q4 2017 | share | Increase | +1.41% | 170K shares | -17.05M | $6.68 | 12.21M |
Q3 2017 | share | Increase | +38.56% | 3.35M shares | 59.60M | $8.19 | 12.04M |
Q2 2017 | share | Increase | 0.00% | 8.69M shares | 39.02M | $4.49 | 8.69M |